© 2022 MJH Life Sciences and Cancer Network. All rights reserved.
© 2022 MJH Life Sciences™ and Cancer Network. All rights reserved.
June 02, 2022
Experts muse on the unmet needs of multiple myeloma, and exciting investigational therapies on the horizon.
A look at the role of bispecifics and CAR T-cell therapies in the multiple myeloma treatment landscape.
May 26, 2022
Experts discuss the case of a woman with relapsed/refractory multiple myeloma and the available treatment options, including novel BCMA-targeted agents.
Key opinion leaders describe the role of blood-based MRD testing in the transplant-ineligible multiple myeloma treatment landscape.
May 19, 2022
Nisha Joseph, MD, presents the case of a 78-year-old man with transplant-ineligible multiple myeloma and discusses treatment strategy.
Experts discuss how they define frail and high-risk patients with multiple myeloma and their treatment approaches for these patient populations.
May 12, 2022
An overview of the study design, efficacy, and safety findings of the MAIA trial.
Dr Nisha Joseph presents the case of a woman with transplant-ineligible multiple myeloma and discusses considerations when choosing frontline treatment regimens.
May 09, 2022
Drs Ajay Nooka and Jonathan Kaufman discuss maintenance and consolidation treatment strategies for transplant eligible multiple myeloma.
Experts discuss how they select a treatment regimen for a newly diagnosed multiple myeloma patient, and how they measure a successful treatment response.